Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
DiabetesHealthy
Interventions
DRUG

repaglinide and metformin combination tablet

Combination tablet of repaglinide (1.0 mg)/metformin (500 mg) given just prior to a standard normal breakfast

DRUG

repaglinide and metformin combination tablet

Combination tablet of repaglinide (2.0 mg)/metformin (500 mg) given just prior to a standard normal breakfast

DRUG

repaglinide

Co-administration of metformin 500 mg tablet and repaglinide 2 mg tablet given just prior to a standard normal breakfast

DRUG

metformin

Concomitant administration: Metformin 500 mg tablet and Repaglinide 2 mg tablet

Trial Locations (1)

100032

Beijing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY